コメントを投稿するにはログインが必要です
ログインページへ記事ができると、章ごとの要約と、聴きどころへ飛べる目次がここに並びます。いまは音声で聴けます。
#5-80E. Real-World Protection: Updated COVID-19 Vaccines in Autoimmune Rheumatic Diseases (Arthritis Rheumatol, 2026)
2026年9月29日 12:00·4分15秒
Do updated COVID-19 vaccines provide meaningful protection for patients with autoimmune rheumatic conditions receiving immunosuppressive therapies? In a national cohort of over 60,000 patients, receipt of updated 2023–2024 COVID-19 vaccines was associated with a 69% reduction in hospitalization odds (aOR 0.31) and substantial protection against critical illness and death compared to unvaccinated individuals. Although potential residual confounding and incomplete EHR vaccination records warrant cautious appraisal, these findings underscore the vital importance of maintaining current vaccination coverage. Clinicians should actively recommend updated COVID-19 boosters to optimize real-world clinical outcomes in this vulnerable population.
Citation: Jackson LE, et al. Updated COVID-19 Vaccines and Health Outcomes in Patients With Autoimmune Rheumatic Conditions. Arthritis & Rheumatology. 2026. DOI: 10.1002/art.70290
URL: https://doi.org/10.1002/art.70290
Disclaimer: This audio summary is based on personal interpretation and does not guarantee the exact content of the original paper. Please refer to the original article for details.
